As shown in Fig. 4, the ACE inhibitor users within the dry climate subgroup showed a considerably higher risk of psoriasis incidence compared to the non-users (OR 3.45, 95% CI 2.05–5.79), whereas the analysis of the temperate climate subgroup showed marginal significance (p = 0.05). This evidence concerns the gene ACE and psoriasis.